Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | Malaria Journal

Figure 1

From: Simulation of the cost-effectiveness of malaria vaccines

Figure 1

Effect of initial efficacy on cost-effectiveness of PEV by transmission setting and delivery modality*. Results obtained assuming a vaccine half-life of 10 years, homogeneity value of 10, and vaccine price of US$2. EPI & Campaigns means EPI with 70% mass vaccination. *data for EIR in some cases are not shown in the figure due to a scale problem.

Back to article page